PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
31.29%
Some net income increase while CRK is negative at -56.25%. John Neff would see a short-term edge over the struggling competitor.
6.89%
Some D&A expansion while CRK is negative at -0.39%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-0.42%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-400.77%
Both reduce yoy usage, with CRK at -70.04%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy usage while CRK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-5042.90%
Negative yoy while CRK is 737.29%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-29.47%
Both yoy CFO lines are negative, with CRK at -31.06%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-25.08%
Both yoy lines negative, with CRK at -43.47%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.03%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-72.10%
Both yoy lines negative, with CRK at -43.47%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-3.15%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
132.61%
We slightly raise equity while CRK is negative at -26.75%. John Neff sees competitor possibly preserving share count or buying back shares.
68.97%
Buyback growth of 68.97% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.